Welcome to our dedicated page for Enhabit SEC filings (Ticker: EHAB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Enhabit, Inc. (NYSE: EHAB) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures as a public issuer. Enhabit, which operates as Enhabit Home Health & Hospice, files reports with the U.S. Securities and Exchange Commission that describe its home health and hospice business, financial performance, governance matters, and executive compensation arrangements.
Through its Form 8-K filings, Enhabit reports material events such as quarterly earnings releases, participation in investor conferences, leadership changes, and stockholder meeting results. For example, the company has filed 8-Ks to furnish its earnings press releases and supplemental information for quarters ended March 31, June 30, and September 30, as well as to describe a CEO transition plan, retention awards for senior officers, and approval of the Enhabit, Inc. 2025 Equity and Incentive Compensation Plan at its annual meeting.
Enhabit’s filings also identify its common stock as registered under Section 12(b) of the Exchange Act and traded on the New York Stock Exchange under the symbol EHAB. The company uses its SEC reports to explain its use of non-GAAP measures such as Adjusted EBITDA, Segment Adjusted EBITDA, Adjusted EPS, and Adjusted free cash flow, and to discuss how unusual or nonrecurring items affect the reconciliation to GAAP results. Same-store comparison methodology for home health and hospice locations is also described in these materials.
On this page, users can review Enhabit’s SEC filings in chronological order, including 8-Ks that detail results of operations and financial condition, regulation FD disclosures, equity plan approvals, and stockholder voting outcomes. Stock Titan’s tools surface these documents alongside AI-powered summaries that highlight key points, helping readers quickly understand how each filing relates to Enhabit’s home health and hospice operations, capital structure, and governance.
Investors and researchers can use this filings archive to follow Enhabit’s reported net service revenue trends, segment performance, executive and director arrangements, and the regulatory context around its home-based care business, all sourced from the company’s official submissions to the SEC’s EDGAR system.
Enhabit, Inc. (EHAB) director Erin Hoeflinger purchased 2,969 shares of the company's common stock on
Enhabit, Inc. (EHAB) filed a Form 4 reporting a director’s share acquisition. On 10/10/2025, the reporting person acquired 2,969 shares of common stock at a price of $8 per share. Following this transaction, the filer beneficially owns 67,850 shares. Ownership is reported as direct.
Stuart M. McGuigan, a director of Enhabit, Inc. (EHAB), reported a purchase of 2,344 shares of the company's common stock on
Enhabit, Inc. (EHAB) director Gregory S. Rush acquired
Insider purchase reported: A director of Enhabit, Inc. (EHAB) acquired 2,344 shares of common stock on
Director Mark W. Ohlendorf reported a non-derivative purchase of 2,344 shares of Enhabit, Inc. (EHAB) on 10/10/2025 at a reported price of
Insider purchase reported: A Form 4 shows director Charles M. Elson acquired 2,344 shares of Enhabit, Inc. (EHAB) on
Insider purchase recorded on Form 4. A director, Jeffrey Bolton, purchased 4,688 shares of Enhabit, Inc. at
Enhabit, Inc. filed a current report describing an upcoming investor-focused appearance by its leadership team. President and Chief Executive Officer Barbara Jacobsmeyer and Chief Financial Officer Ryan Solomon will take part in a fireside chat at the Jefferies 2025 Healthcare Services Conference on September 30, 2025, at 10:55 a.m. Central Time. The session will be webcast live and available for replay through the company’s investor relations website at https://investors.ehab.com.
The company has also prepared an investor presentation for this event and attached it as Exhibit 99.1. This presentation is being furnished under Regulation FD, meaning it is provided for informational purposes and is not deemed filed for liability purposes under the securities laws unless later specifically incorporated by reference.
Enhabit, Inc. received a joint Schedule 13G/A reporting that a group of related investment entities and an individual, collectively the "Reporting Persons," hold 3,853,067 shares of Enhabit common stock, representing 7.61% of the outstanding class based on 50,637,417 shares outstanding. The holdings are held across affiliated vehicles: 8 Knots Fund (2,035,999 shares, 4.02%), 8 Knots Fund II (170,645 shares, 0.34%), and other affiliated entities that together account for the aggregate position.
The filing identifies 8 Knots Management, LLC as an SEC-registered investment adviser and names Scott Green as its managing member; 8 Knots Management and Mr. Green disclaim beneficial ownership of certain sub-advised and separately managed account positions, while acknowledging shared voting and dispositive power over the disclosed aggregate position. The filing includes a joint filing agreement among the Reporting Persons and a certification that the securities are held in the ordinary course of business and not for the purpose of changing or influencing control.